US Stock MarketDetailed Quotes
DSNKY Daiichi Sankyo (ADR)
- 37.510
- +0.120+0.32%
15min DelayClose Jul 22 16:00 ET
71.61BMarket Cap56.32P/E (TTM)
37.730High37.320Low30.15KVolume37.730Open37.390Pre Close1.13MTurnover0.00%Turnover Ratio56.32P/E (Static)1.91BShares38.58052wk High6.68P/B71.61BFloat Cap23.72052wk Low0.33Dividend TTM1.91BShs Float38.580Historical High0.87%Div YieldTTM1.10%Amplitude18.050Historical Low37.478Avg Price1Lot Size
About Daiichi Sankyo (ADR) Company
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
Company Profile
SymbolDSNKY
Company NameDaiichi Sankyo (ADR)
Founded2005
CEOMr. Sunao Manabe
MarketPink Market
Employees14887
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
AddressDaiichi Sankyo Head Office Bldg, A&B,3-5-1 Nihonbashi-honcho,Chuo-Ku
CityTokyo
ProvinceTokyo
CountryJapan
Zip Code103-8426
Phone81-3-6225-1111
Company Executives
- Name
- Position
- Salary
- Sunao Manabe
- Executive Chairman of the Board and Chief Executive Officer
- --
- Takashi Matsumoto
- Director, Managing Executive Officer, Chief Human Resources Officer and Head of Global HR
- --
- Hiroyuki Okuzawa
- Director, President and Chief Operating Officer
- --
- Takashi Fukuoka
- Director, Senior Executive Officer and Head, Global Corporate Strategy
- --
- Shoji Hirashima
- Director, Senior Executive Officer and Head, Japan Business Unit
- --
- Kazuaki Kama
- Chairman of the Board
- --
- Takaaki Nishii
- Independent Director
- --
- Sawako Nohara
- Independent Director
- --
- Yo Honma
- Independent Director
- --
- Yasuhiro Komatsu
- Independent Director
- --
Analysis
Price Target
No Data
Business Data
Revenue by product
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
